OBJECTIVE: The Trust in Oncologist Scale (TiOS) was recently developed and validated in The Netherlands to assess cancer patients' trust in their oncologist. In this study, we translated and further validated the scale amongst English-speaking Australian cancer patients, to establish cross-cultural validity. METHODS: The translated 18-item scale was administered to cancer patients (n = 175) from three Sydney hospitals. In addition to trust, we assessed patients' satisfaction, trust in health care, and background characteristics. Dimensionality, internal consistency, and construct validity of the translated scale were assessed. RESULTS: Psychometric properties of all items were acceptable. Trust scores were very high. Factor analyses indicated one-dimensionality of the scale. Internal consistency was strong. Moderate to high correlations were found between trust (TiOS) and its known correlates, i.e., satisfaction, number of previous consultations with the oncologist, and trust in health care, indicating good construct validity. CONCLUSION: Trust is highly coherent, suggesting that cancer patients do not distinguish between separate dimensions of trust. Future research could clarify if trust is equally strong and one-dimensional among specific groups of cancer patients. PRACTICE IMPLICATIONS: Both the English and the Dutch Trust in Oncologist Scales appear suitable for assessing cancer patients' trust reliably and validly.
OBJECTIVE: The Trust in Oncologist Scale (TiOS) was recently developed and validated in The Netherlands to assess cancerpatients' trust in their oncologist. In this study, we translated and further validated the scale amongst English-speaking Australian cancerpatients, to establish cross-cultural validity. METHODS: The translated 18-item scale was administered to cancerpatients (n = 175) from three Sydney hospitals. In addition to trust, we assessed patients' satisfaction, trust in health care, and background characteristics. Dimensionality, internal consistency, and construct validity of the translated scale were assessed. RESULTS: Psychometric properties of all items were acceptable. Trust scores were very high. Factor analyses indicated one-dimensionality of the scale. Internal consistency was strong. Moderate to high correlations were found between trust (TiOS) and its known correlates, i.e., satisfaction, number of previous consultations with the oncologist, and trust in health care, indicating good construct validity. CONCLUSION: Trust is highly coherent, suggesting that cancerpatients do not distinguish between separate dimensions of trust. Future research could clarify if trust is equally strong and one-dimensional among specific groups of cancerpatients. PRACTICE IMPLICATIONS: Both the English and the Dutch Trust in Oncologist Scales appear suitable for assessing cancerpatients' trust reliably and validly.
Authors: I Henselmans; E M A Smets; J C J M de Haes; M G W Dijkgraaf; F Y de Vos; H W M van Laarhoven Journal: BMC Cancer Date: 2018-01-08 Impact factor: 4.430
Authors: Marij A Hillen; Hanneke C J M de Haes; Geertjan van Tienhoven; Nina Bijker; Hanneke W M van Laarhoven; Daniëlle M Vermeulen; Ellen M A Smets Journal: Breast Cancer Res Treat Date: 2015-07-31 Impact factor: 4.872